Sign in
8-K

Current Report

Fulcrum Therapeutics, Inc. Filed Acc 0001193125-22-168375

Agreement ended

  • Item 1.02 Termination of a material definitive agreement

From the SEC's structured data for this filing

Loading d318754d8k.htm…